Dr. Emma Ester Bendana, MD

Dr. Bendana practices at Rio Grande Urology PA in Las Cruces, New Mexico.

Dr. Bendana's NPI, 1235303512, was assigned on April 17, 2008. Dr. Bendana graduated from Albany Medical College of Union University in 2008. Dr. Bendana holds New Mexico license MD2015-0519.

Dr. Bendana's primary practice is Rio Grande Urology PA, at 2545 Don Roser Dr, Las Cruces, NM 88011 in Dona Ana County. The practice phone is (915) 532-8823.

Dr. Bendana's primary practice is Rio Grande Urology PA in Las Cruces, New Mexico. Dr. Bendana is also affiliated with Memorial Medical Center. The medical group on file is Rio Grande Urology. Dmand AI also links Dr. Bendana to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bendana practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bendana's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Bendana's licenses on file in 2 states: New Mexico and Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Bendana treats.

CMS data shows 4,934 Medicare services from Dr. Bendana across 29 procedure codes in 2024, for 895 Medicare patients. Medicare paid $204,870 for them.

CMS counts 895 Medicare patients who saw Dr. Bendana in 2026. The largest group is 65 to 74, with 375 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bendana's median patient age at 71, with 40% women.

In 2026, Dr. Bendana wrote 1,392 Medicare Part D claims for 506 patients. 89% of them were for generic drugs. CMS names the drug for 1,260 of them, across 23 drugs with 11 or more claims each, at $155,647 in total drug cost. In 2023, CMS named 1,876 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bendana for performance year 2026, reported as part of a group. Dr. Bendana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bendana as offering telehealth. CMS counts 12 procedures of prostate resection by Dr. Bendana, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Bendana in 2015. Dr. Bendana's most frequent co-authors are Vineet Agrawal, MD, PhD and Hani H. Rashid, MD.

CMS Open Payments shows 332 general payments to Dr. Bendana from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Boston Scientific Corporation paid the most, $10,423.

Dr. Bendana graduated from Albany Medical College of Union University in 2008.

Dr. Bendana is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.